Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 197

1.

HER2 Assessment in Upper Gastrointestinal Tract Adenocarcinoma: A Practical, Algorithmic Approach.

Davison JM, Pai RK.

Surg Pathol Clin. 2013 Sep;6(3):391-403. doi: 10.1016/j.path.2013.05.001. Epub 2013 Jul 19.

PMID:
26839094
2.

A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes.

Davison JM, Landau MS, Luketich JD, McGrath KM, Foxwell TJ, Landsittel DP, Gibson MK, Nason KS.

Clin Gastroenterol Hepatol. 2015 Oct 26. pii: S1542-3565(15)01486-X. doi: 10.1016/j.cgh.2015.10.020. [Epub ahead of print]

PMID:
26515637
3.

TissueCypher(â„¢): A systems biology approach to anatomic pathology.

Prichard JW, Davison JM, Campbell BB, Repa KA, Reese LM, Nguyen XM, Li J, Foxwell T, Taylor DL, Critchley-Thorne RJ.

J Pathol Inform. 2015 Aug 31;6:48. doi: 10.4103/2153-3539.163987. eCollection 2015.

4.

Paired exome analysis of Barrett's esophagus and adenocarcinoma.

Stachler MD, Taylor-Weiner A, Peng S, McKenna A, Agoston AT, Odze RD, Davison JM, Nason KS, Loda M, Leshchiner I, Stewart C, Stojanov P, Seepo S, Lawrence MS, Ferrer-Torres D, Lin J, Chang AC, Gabriel SB, Lander ES, Beer DG, Getz G, Carter SL, Bass AJ.

Nat Genet. 2015 Sep;47(9):1047-55. doi: 10.1038/ng.3343. Epub 2015 Jul 20.

PMID:
26192918
5.

The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma.

Zahoor H, Luketich JD, Weksler B, Winger DG, Christie NA, Levy RM, Gibson MK, Davison JM, Nason KS.

Am J Surg. 2015 Oct;210(4):610-7. doi: 10.1016/j.amjsurg.2015.05.010. Epub 2015 Jun 26.

PMID:
26188709
6.

Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.

Derks S, Nason KS, Liao X, Stachler MD, Liu KX, Liu JB, Sicinska E, Goldberg MS, Freeman GJ, Rodig SJ, Davison JM, Bass AJ.

Cancer Immunol Res. 2015 Oct;3(10):1123-9. doi: 10.1158/2326-6066.CIR-15-0046. Epub 2015 Jun 16.

PMID:
26081225
7.

Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.

Singhi AD, Foxwell TJ, Nason K, Cressman KL, McGrath KM, Sun W, Bahary N, Zeh HJ, Levy RM, Luketich JD, Davison JM.

Am J Surg Pathol. 2015 Apr;39(4):487-95. doi: 10.1097/PAS.0000000000000356.

PMID:
25634752
8.

Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.

Singhi AD, Seethala RR, Nason K, Foxwell TJ, Roche RL, McGrath KM, Levy RM, Luketich JD, Davison JM.

Hum Pathol. 2015 Mar;46(3):366-75. doi: 10.1016/j.humpath.2014.11.021. Epub 2014 Dec 17.

PMID:
25582499
9.

Breast-feeding after transplantation.

Constantinescu S, Pai A, Coscia LA, Davison JM, Moritz MJ, Armenti VT.

Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1163-73. doi: 10.1016/j.bpobgyn.2014.09.001. Epub 2014 Sep 16. Review.

PMID:
25271063
10.

Immunosuppressive drugs and fetal outcome.

Coscia LA, Constantinescu S, Davison JM, Moritz MJ, Armenti VT.

Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1174-87. doi: 10.1016/j.bpobgyn.2014.07.020. Epub 2014 Aug 7. Review.

PMID:
25175414
11.

The inflammatory bowel disease live interinstitutional and interdisciplinary videoconference education (IBD LIVE) series.

Regueiro MD, Greer JB, Binion DG, Schraut WH, Goyal A, Keljo DJ, Cross RK, Williams ED, Herfarth HH, Siegel CA, Oikonomou I, Brand MH, Hartman DJ, Tublin ME, Davis PL, Baidoo L, Szigethy E, Watson AR; IBD LIVE Physician Group.

Inflamm Bowel Dis. 2014 Oct;20(10):1687-95. doi: 10.1097/MIB.0000000000000187.

PMID:
25167213
12.

Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.

Zaidi AH, Gopalakrishnan V, Kasi PM, Zeng X, Malhotra U, Balasubramanian J, Visweswaran S, Sun M, Flint MS, Davison JM, Hood BL, Conrads TP, Bergman JJ, Bigbee WL, Jobe BA.

Cancer. 2014 Dec 15;120(24):3902-13. doi: 10.1002/cncr.28963. Epub 2014 Aug 5.

13.

GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.

Singhi AD, Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Mantha G, Nikiforova M, Bartlett DL, Pai RK.

Hum Pathol. 2014 Aug;45(8):1737-43. doi: 10.1016/j.humpath.2014.04.018. Epub 2014 May 8.

PMID:
24925222
14.

Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.

Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM.

Mod Pathol. 2014 Dec;27(12):1578-89. doi: 10.1038/modpathol.2014.66. Epub 2014 Apr 25.

15.

The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Conrad KP, Davison JM.

Am J Physiol Renal Physiol. 2014 May 15;306(10):F1121-35. doi: 10.1152/ajprenal.00042.2014. Epub 2014 Mar 19. Review.

16.

Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade.

Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Zhu B, Nikiforova M, Bartlett DL, Pai RK.

Mod Pathol. 2014 Nov;27(11):1521-39. doi: 10.1038/modpathol.2014.37. Epub 2014 Mar 14.

17.

Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms.

Davison JM, Hartman DA, Singhi AD, Choudry HA, Ahrendt SA, Zureikat AH, Ramalingam L, Nikiforova M, Pai RK.

Am J Surg Pathol. 2014 May;38(5):583-92. doi: 10.1097/PAS.0000000000000194.

PMID:
24618609
18.

The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.

Davison JM, Yee M, Krill-Burger JM, Lyons-Weiler MA, Kelly LA, Sciulli CM, Nason KS, Luketich JD, Michalopoulos GK, LaFramboise WA.

PLoS One. 2014 Jan 16;9(1):e79079. doi: 10.1371/journal.pone.0079079. eCollection 2014.

19.

MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.

Davison JM, Ellis ST, Foxwell TJ, Luketich JD, Gibson MK, Kuan SF, Nason KS.

Hum Pathol. 2014 Mar;45(3):540-8. doi: 10.1016/j.humpath.2013.10.020. Epub 2013 Oct 30.

20.

Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.

Malhotra U, Zaidi AH, Kosovec JE, Kasi PM, Komatsu Y, Rotoloni CL, Davison JM, R C, Irvin, Hoppo T, Nason KS, Kelly LA, Gibson MK, Jobe BA.

PLoS One. 2013 Nov 4;8(11):e78343. doi: 10.1371/journal.pone.0078343. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk